Disease-modifying drugs (DMARDs), Psoriatic arthritis, Real-world evidence

被引：1
|
作者：
Song, J. [1 ,2 ]
Abe, C. [1 ,2 ]
Banefelt, J. [3 ]
Rieem-Dun, A. [3 ]
Willems, D. [1 ]
Morup, M. [1 ]
Taieb, V. [1 ]
Lindberg, I. [1 ]
Welby, S. [1 ]
机构：
[1] UCB Pharma, Braine Lalleud, Belgium
[2] Karolinska Inst, Stockholm, Sweden
[3] Quantify Res, Stockholm, Sweden
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Disease-modifying drugs (DMARDs); Psoriatic arthritis; Real-world evidence;
D O I：
10.1136/annrheumdis-2023-eular.3573
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1785 / 1786
页数：2
相关论文
共 50 条
  • [31] An overview of biologic disease-modifying antirheumatic drugs in axial spondyloarthritis and psoriatic arthritis
    So, Anthony
    Inman, Robert Davies
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2018, 32 (03): : 453 - 471
  • [32] Combination of Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs in Psoriatic Arthritis
    Ribeiro, Andre Lucas
    Abarza, Virginia Carrizo
    Gladman, Dafna
    Chandran, Vinod
    Eder, Lihi
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4728 - 4730
  • [33] Effectiveness of conventional disease-modifying antirheumatic drugs in psoriatic arthritis: A systematic review
    Maese, Jesus
    Diaz del Campo, Petra
    Seoane-Mato, Daniel
    Guerra, Mercedes
    Canete, Juan D.
    REUMATOLOGIA CLINICA, 2018, 14 (02): : 81 - 89
  • [34] Termination of disease-modifying drugs in psoriatic arthritis: Study of 109 courses of treatment
    GomezVaquero, C
    RodriguezMoreno, J
    Ros, S
    Marcos, R
    Fiter, J
    RoigEscofet, D
    BRITISH JOURNAL OF RHEUMATOLOGY, 1996, 35 (06): : 564 - 567
  • [35] The Actual Role of Therapy with Traditional Disease-modifying Antirheumatic Drugs in Psoriatic Arthritis
    Soriano, Enrique R.
    JOURNAL OF RHEUMATOLOGY, 2012, 39 : 67 - 70
  • [36] Disease-modifying antirheumatic drugs improve cardiovascular autonomic neuropathy in psoriatic arthritis
    Syngle, Ashit
    Verma, Inderjeet
    Krishan, Pawan
    Syngle, Vijaita
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2016, 8 (02) : 42 - 48
  • [37] REAL-WORLD EVIDENCE ON ASSESSING PSORIATIC ARTHRITIS BY DISEASE DOMAIN: AN EVALUATION OF THE COREVITAS PSORIATIC ARTHRITIS/SPONDYLOARTHRITIS REGISTRY
    Mease, P. J.
    Blachley, T.
    O'brien, J.
    Middaugh, N.
    Kricorian, G.
    Stryker, S.
    Collier, D.
    Ogdie, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 406 - 407
  • [38] Real-World Evidence Assessing Psoriatic Arthritis by Disease Domain: An Evaluation of the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
    Mease, Philip J.
    O'Brien, Jacqueline
    Middaugh, Nicole
    Kricorian, Gregory
    Stryker, Scott
    Collier, David H.
    Ogdie, Alexis
    ACR OPEN RHEUMATOLOGY, 2023, 5 (08) : 388 - 398
  • [39] REAL-WORLD EVIDENCE FOR DISEASE -MODIFYING DRUGS IN MULTIPLE SCLEROSIS: TRENDS IN THE LITERATURE
    Edwards, N. C.
    Beckerman, R.
    Phillips, A. L.
    VALUE IN HEALTH, 2017, 20 (05) : A189 - A189
  • [40] Disease-Modifying Antirheumatic Drugs (DMARDs) and drug interactions in dentistry
    Munoz-Martinez, C.
    Segura-Puertas, M.
    Gomez-Moreno, G.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (07) : 2834 - 2842
12345